Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Rh Blood Group01:19

Rh Blood Group

1.8K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.8K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

1.2K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.2K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

241
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
241
Hemoglobin01:24

Hemoglobin

4.4K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
4.4K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Newborn Screening for Hemoglobinopathies and Thalassemias: Brief History, Recent Activities, and Global Status-2026.

International journal of neonatal screening·2026
Same author

Consolidated Newborn Bloodspot Screening Efforts in Developing Countries in the Asia Pacific-2024.

International journal of neonatal screening·2025
Same author

Development, Validation, and Application of the Paya Hamsan Technologies Underivatized Newborn Screening Assay (PHUNSA) for Inborn Metabolic Disorders in Dried Blood Spot Samples from Iranian Infants.

International journal of neonatal screening·2025
Same author

Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).

International journal of neonatal screening·2024
Same author

Newborn Screening Long-Term Follow-Up Clinics (Continuity Clinics) in the Philippines during the COVID-19 Pandemic: Continuing Quality Patient Care.

International journal of neonatal screening·2023
Same author

Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors.

International journal of neonatal screening·2022
Same journal

Breathing Physiology into the Art of Neonatal Respiratory Care.

Clinics in perinatology·2026
Same journal

The Science and Art of Neonatal Respiratory Care.

Clinics in perinatology·2026
Same journal

Ex Utero Artificial Womb Support: Promising Future for Extremely Preterm Infants.

Clinics in perinatology·2026
Same journal

Advances in the Use of Cell-Based Therapies for Prevention of Bronchopulmonary Dysplasia.

Clinics in perinatology·2026
Same journal

Evaluation and Management of Genetic Respiratory Disorders Presenting as Hypoxemic Respiratory Failure in the Newborn Infant.

Clinics in perinatology·2026
Same journal

Modern Surfactant Delivery Methods with a Focus on Implementation of Surfactant Administration Through Laryngeal and Supraglottic Airways.

Clinics in perinatology·2026
関連記事をすべて見る

関連する実験動画

Updated: Sep 10, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K

新生児におけるヘモグロビン疾患のスクリーニング

Bradford L Therrell1

  • 1Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; U.S. National Newborn Screening and Global Resource Center, 3907 Galacia Drive, Austin, TX 78759, USA.

Clinics in perinatology
|August 24, 2025
PubMed
まとめ
この要約は機械生成です。

新生児のヘモグロビノパシーのスクリーニングは1975年以来進化し,状細胞疾患を超えて拡大しました. 高い罹患率の地域でのスクリーニングの制限は,世界の健康格差を強調しています.

キーワード:
乾いた血の斑点ヘモグロビノパシー新生児のスクリーニングタラセミア世界保健機関

さらに関連する動画

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.1K
A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering
05:18

A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering

Published on: December 7, 2016

9.8K

関連する実験動画

Last Updated: Sep 10, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K
Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.1K
A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering
05:18

A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering

Published on: December 7, 2016

9.8K

科学分野:

  • 医学 遺伝学
  • 公衆衛生
  • 小児科

背景:

  • 1975 年 に ニューヨーク で,状 細胞 病 を 含む 新生児 の ヘモグロビノパシー の 検診 が 開始 さ れ まし た.
  • 臨床的に重要な様々なヘモグロビン疾患を検知するためのスクリーニングプログラムが拡大されています.
  • サハラ以南のアフリカ,カリブ海,インドなどの高流行地域でのスクリーニングは限られています.

研究 の 目的:

  • 新生児のヘモグロビノパシーとタラセミアのスクリーニングの歴史的発展をレビューする.
  • 新生児のヘモグロビン疾患のスクリーニングにおける現在の活動と動向に関する最新情報を提供すること.
  • 新生児のヘモグロビノパシー検査へのアクセスにおける世界的な不平等を強調する.

主な方法:

  • 新生児の新血球病のスクリーニングプログラムの歴史的レビュー
  • スクリーニング範囲の進化を分析する.
  • スクリーニングの実施における地理的格差の検討

主要な成果:

  • 新生児のヘモグロビノパシーのスクリーニングは,その開始以来大幅に進歩しました.
  • 現在では 状細胞病以外にも ヘモグロビン疾患の範囲が広がっています
  • 世界の主要地域では,スクリーニングの範囲に重大な欠陥が残っています.

結論:

  • 新生児のヘモグロビノパシーのスクリーニングは 進化と拡大の豊かな歴史があります
  • 検診へのアクセスにおける世界的な不平等に対処することは,健康成果の改善に不可欠です.
  • 世界中でヘモグロビノパシーとタラセミアのスクリーニングを拡大するために,継続的な努力が必要です.